QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-united-therapeutics-raises-price-target-to-525

HC Wainwright & Co. analyst Andrew S. Fein maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price t...

 rbc-capital-maintains-outperform-on-united-therapeutics-raises-price-target-to-587

RBC Capital analyst Lisa Walter maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target fr...

 wells-fargo-maintains-equal-weight-on-united-therapeutics-raises-price-target-to-423

Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...

 sp-500-tops-6900-ahead-fed-rate-move-gold-reclaims-4000-whats-moving-markets-wednesday

A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelle...

 united-therapeutics-to-present-latest-pulmonary-hypertension-data-at-chest-2025-in-chicago

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced two presentations at the upcoming...

 morgan-stanley-maintains-equal-weight-on-united-therapeutics-raises-price-target-to-435

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...

 ubs-maintains-buy-on-united-therapeutics-raises-price-target-to-580

UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ: UTHR) with a Buy and raises the price target from $560 to $...

 this-united-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 rbc-capital-initiates-coverage-on-united-therapeutics-with-outperform-rating-announces-price-target-of-569

RBC Capital analyst Lisa Walter initiates coverage on United Therapeutics (NASDAQ: UTHR) with a Outperform rating and announ...

 united-therapeutics-to-showcase-new-lung-disease-research-at-major-european-medical-conference

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its c...

 cantor-fitzgerald-maintains-overweight-on-united-therapeutics-raises-price-target-to-525

Cantor Fitzgerald analyst Olivia Brayer maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price t...

 wayfair-united-therapeutics-and-ciena-are-among-the-top-10-large-cap-gainers-last-week-sep-1-sep5-are-the-others-in-your-portfolio-corrected

These ten large-cap stocks were top performers last week. Are they a part of your portfolio?

 oppenheimer-maintains-outperform-on-united-therapeutics-raises-price-target-to-575

Oppenheimer analyst Andreas Argyrides maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price tar...

 hc-wainwright--co-maintains-buy-on-united-therapeutics-raises-price-target-to-500

HC Wainwright & Co. analyst Andrew Fein maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION